Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the device’s outflow graft assembly. The company said the malfunction may cause the...
Cardiovascular Surgery
This channel includes news and new technology innovations for cardiac surgery. This includes coronary bypass grafts, surgical valve replacements.
-
-
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with ...
-
The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of the mandatory hip fracture and cardiac bundled payment models that were to be operated by the CMS...
-
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number of mandatory geographic areas participating in the Center for Medicare and...
News | Ventricular Assist Devices (VAD) | May 23, 2018
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...
News | Heart Valve Technology | March 30, 2018
March 30, 2018 — LivaNova PLC announced the first patient enrollment in the Perceval Valve...
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
February 27, 2018 – A new study published in the Journal of the American College of Cardiology confirms non-invasive...
Technology | Left Atrial Appendage (LAA) Occluders | February 22, 2018
February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V...
News | Hemodynamic Support Devices | January 25, 2018
January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support...
News | Stem Cell Therapies | January 17, 2018
January 17, 2018 — Secant Group, in partnership with its sister company SanaVita Medical, announced new technology...
News | Cardiovascular Business | December 21, 2017
December 21, 2017 — The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of...
News | Artificial Heart | December 11, 2017
December 11, 2017 — CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life...
News | November 25, 2017
November 25, 2017 — The majority of patients without health insurance who were hospitalized for heart attack, stroke...
News | Heart Failure | November 17, 2017
November 17, 2017 — Common practice, and recently published research, shows that the risk of complications with...
Transparent Stratasys 3-D-printed model of a patient-specific aortic arch, used by the University Hospital Mainz to practice complex endovascular surgeries. Photo courtesy of Business Wire.
News | Medical 3-D Printing | November 16, 2017
November 16, 2017 — Stratasys Ltd. announced that surgeons at the University of Mainz Cardiothoracic and Vascular...
Study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, explaining the HREVS trial results at TCT 2017.
News | November 06, 2017 | Dave Fornell
November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different...
News | Heart Valve Technology | November 01, 2017
November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found...
